Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial

Hemochromatosis classification: update and recommendations by the BIOIRON Society

(2021) Domenico Girelli et al.   BLOOD

Iron metabolism and iron disorders revisited in the hepcidin era

(2020) Clara Camaschella et al.   HAEMATOLOGICA

ACG Clinical Guideline

(2019) Kris V. Kowdley et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Hepcidin agonists as therapeutic tools

(2018) Carla Casu et al.   BLOOD

Liver Iron Quantification with MR Imaging: A Primer for Radiologists

(2018) Roxanne Labranche et al.   RADIOGRAPHICS

Haemochromatosis

(2018) Pierre Brissot et al.   Nature Reviews Disease Primers

Measurement of liver iron by magnetic resonance imaging in the UK Biobank population

(2018) Andy McKay et al.   PLoS One

Minihepcidin peptides as disease modifiers in mice affected by  -thalassemia and polycythemia vera

(2016) C. Casu et al.   BLOOD

How we manage patients with hereditary haemochromatosis

(2016) Eva Rombout-Sestrienkova et al.   BRITISH JOURNAL OF HAEMATOLOGY

Haemochromatosis

(2016) Lawrie W Powell et al.   LANCET

Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study

(2015) Rodolfo Cançado et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data

(2015) Daniel F. Wallace et al.   GENETICS IN MEDICINE

Hepcidin and iron disorders: new biology and clinical approaches

(2015) J. Arezes et al.   International Journal of Laboratory Hematology

The pathophysiology and pharmacology of hepcidin

(2014) Piotr Ruchala et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis

(2012) E. Ramos et al.   BLOOD

Hereditary hemochromatosis: Mutations in genes involved in iron homeostasis in Brazilian patients

(2011) Paulo C.J.L. Santos et al.   BLOOD CELLS MOLECULES AND DISEASES

Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload

(2011) Gloria C. Preza et al.   JOURNAL OF CLINICAL INVESTIGATION

A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis

(2010) Pradyumna Phatak et al.   HEPATOLOGY

Hereditary hemochromatosis: patient experiences of the disease and phlebotomy treatment

(2010) Pierre Brissot et al.   TRANSFUSION

Iron overload in the Asian community

(2009) C. Y. Lok et al.   BLOOD

Immunoassay for human serum hepcidin

(2008) T. Ganz et al.   BLOOD

Iron-Overload–Related Disease inHFEHereditary Hemochromatosis

(2008) Katrina J. Allen et al.   NEW ENGLAND JOURNAL OF MEDICINE